MERCK

Drug Name	Phase	Indication	Designations	Patent
Enfortumab vedotin (EV)	Phase 3	Bladder Cancer	-	-
losartan potassium	Phase 3	Hypertension	-	-
anacetrapib	Phase 3	Coronary Heart Disease (CHD)	-	-
Suvorexant Low Dose (LD)	Phase 3	Primary Insomnia	-	-
dorzolamide hydrochloride (+) timolol maleate	Phase 3	Glaucoma	-	-
rofecoxib	Phase 3	Prostate Cancer	-	-
ProQuad®	Phase 3	Measles	-	-
RotaTeq™, rotavirus vaccine, live, oral, pentavalent	Phase 3	Rotavirus Infections	-	-
Quadrivalent Human Papillomavirus (HPV, Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)	Phase 3	Papillomavirus Infections	-	-
Infliximab + methotrexate (IFX + MTX)	Phase 3	Arthritis, Psoriatic	-	-
Rebif New Formulation + prophylactic Ibuprofen	Phase 3	Relapsing Multiple Sclerosis	-	-
PPSV23	Phase 3	Pneumococcal Disease	-	-
Boceprevir	Phase 3	Chronic Hepatitis C Genotype 1	-	-
Esmirtazapine	Phase 3	Insomnia	-	-
hydrochlorothiazide (HCTZ)	Phase 3	Hypertension	-	-
PNEUMOVAX™23	Phase 3	Pneumococcal Infections	-	-
Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)	Phase 3	Head and Neck Cancer	-	-
Ertapenem sodium	Phase 3	Infection; Diabetic Foot	-	-
MK0826, ertapenem sodium / Duration of Treatment: 14 Days	Phase 3	Infection	-	-
Prednisone	Phase 3	Prostatic Neoplasms	-	-
pneumococcal 23v polysaccharide vaccine	Phase 3	Pneumococcal Infection	-	-
niacin (+) laropiprant (+) simvastatin	Phase 3	Primary Hypercholesterolemia	-	-
Modified Process Hepatitis B Vaccine (Experimental)	Phase 3	Hepatitis B	-	-
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™)	Phase 3	Papillomavirus Infections	-	-
V212	Phase 3	Herpes Zoster	-	-
Dexamethasone 4 mg	Phase 3	Non-Small-Cell Lung Carcinoma	-	-
Combination of pegylated interferon alfa-2b (PEG-Intron®) and ribavirin (Rebetol®)	Phase 3	Hepatitis C, Chronic	-	-
Open-label Metformin	Phase 3	Type 2 Diabetes	-	-
Olaparib	Phase 3	Ovarian Cancer	-	-
Lantus™	Phase 3	Type 2 Diabetes Mellitus	-	-
Raptiva	Phase 3	Moderate to Severe Psoriasis	-	-
Pembrolizumab 400 mg	Phase 3	Small Cell Lung Cancer	-	-
mRNA-1273 Vaccine	Phase 3	Papillomavirus Infections	-	-
docetaxel	Phase 3	Endometrial Neoplasms	-	-
Rescue Medications	Phase 3	Cervical Cancer	-	-
MTX	Phase 3	Arthritis, Rheumatoid	-	-
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine	Phase 3	Cervical Cancer	-	-
V920 Consistency Lot A	Phase 3	Prevention of Ebola Infection	-	-
Peginterferon alfa-2a	Phase 3	Hepatitis C, Chronic	-	-
Letermovir	Phase 3	Cytomegalovirus Infection	-	-
Sacituzumab tirumotecan	Phase 3	Colorectal Cancer	-	-
V232 Modified Process Hepatitis B Vaccine: Lot A	Phase 3	Hepatitis B Infection	-	-
PCV13	Phase 3	Pneumococcal Infections	-	-
Varicella Virus Vaccine Live (2007 Process) (Oka/Merck)	Phase 3	Varicella	-	-
Ribavirin	Phase 3	Hepatitis C	-	-
Anacetrapib 100 mg	Phase 3	Hypercholesterolemia	-	-
Tobramycin	Phase 3	Bacterial Conjunctivitis	-	-
Pegylated interferon alfa-2b	Phase 3	Hepatitis C	-	-
Basal Insulin	Phase 3	Type 2 Diabetes Mellitus	-	-
0.9% sodium chloride (NaCl)	Phase 3	Anesthesia	-	-
sac-TMT	Phase 3	Non-small Cell Lung Cancer	-	-
Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)	Phase 3	Chronic Hepatitis C	-	-
Org 50081	Phase 3	Insomnia	-	-
HBVAXPRO™	Phase 3	Hepatitis B	-	-
VARIVAX™	Phase 3	Varicella	-	-
SC Tulisokibart	Phase 3	Ulcerative Colitis	-	-
Insulin	Phase 3	Type 2 Diabetes Mellitus	-	-
Vericiguat	Phase 3	Heart Failure	-	-
DAPTACEL™	Phase 3	Bacterial Infections	-	-
etoposide	Phase 3	Carcinoma, Non-Small-Cell Lung	-	-
IMI/REL FDC	Phase 3	Hospital-Acquired Bacterial Pneumonia	-	-
sitagliptin 100 mg q.d./pioglitazone 30 mg q.d	Phase 3	Type 2 Diabetes Mellitus	-	-
Vicriviroc	Phase 3	HIV Infections	-	-
Molnupiravir	Phase 3	Coronavirus Disease (COVID-19)	-	-
losartan potassium + hydrochlorothiazide + amlodipine besylate (MK-0954E)	Phase 3	Hypertension	-	-
ertapenem sodium (MK0826)	Phase 3	Urinary Tract Infection	-	-
Pegylated liposomal doxorubicin (SCH 200746)	Phase 3	Breast Cancer	-	-
Enzalutamide	Phase 3	Metastatic Hormone-Sensitive Prostate Cancer	-	-
peginterferon alfa-2b (SCH 54031)	Phase 3	Chronic Hepatitis C	-	-
Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin	Phase 3	Hepatitis C, Chronic	-	-
Pembrolizumab SC	Phase 3	Non-Small Cell Lung Cancer	-	-
ISL	Phase 3	Human Immunodeficiency Virus Type 1 (HIV-1) Infection	-	-
TR-701 FA	Phase 3	Skin and Subcutaneous Tissue Bacterial Infections	-	-
Neostigmine	Phase 3	Anesthesia	-	-
5-Fluorouracil	Phase 3	Uterine Cervical Neoplasms	-	-
CB-183,315	Phase 3	Clostridium Difficile Infection	-	-
Pioglitazone	Phase 3	Type 2 Diabetes Mellitus	-	-
ceftriaxone sodium	Phase 3	Infection	-	-
PCV15	Phase 3	Pneumonia, Pneumococcal	-	-
eribulin	Phase 3	Metastatic Triple Negative Breast Cancer	-	-
Sitagliptin 50 mg	Phase 3	Type 2 Diabetes Mellitus	-	-
Preservative-Free Tafluprost or vehicle	Phase 3	Glaucoma	-	-
Preladenant 2 mg tablet	Phase 3	Parkinson Disease	-	-
Recombinant human luteinizing hormone (r-hLH)	Phase 3	Hypogonadism	-	-
Experimental: V503	Phase 3	Cervical Cancer	-	-
Peginterferon alfa-2b (PegIntron, SCH 54031)	Phase 3	Hepatitis D, Chronic	-	-
RNF	Phase 3	Multiple Sclerosis	-	-
H1 receptor antagonist	Phase 3	Ovarian Cancer	-	-
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years	Phase 3	Cervical Cancer	-	-
Telcagepant potassium 150 mg	Phase 3	Migraine	-	-
Hepatitis A Vaccine, Purified Inactivated (VAQTA™)	Phase 3	Hepatitis A Virus Infection	-	-
Vancomycin	Phase 3	Clostridium Difficile Infection	-	-
Sugammadex 0.5 mg/kg	Phase 3	Anesthesia	-	-
Ondansetron	Phase 3	Chemotherapy-Induced Nausea and Vomiting (CINV)	-	-
irinotecan	Phase 3	Esophageal Carcinoma	-	-
Dinaciclib	Phase 3	Chronic Lymphocytic Leukemia (CLL)	-	-
ATRIPLA™	Phase 3	Human Immunodeficiency Virus (HIV)	-	-
simvastatin 20 mg/ezetimibe	Phase 3	Hyperlipidemia	-	-
Anagrelide	Phase 3	Essential Thrombocythemia	-	-
ULO	Phase 3	Human Immunodeficiency Virus Type 1 (HIV-1) Infection	-	-
Telcagepant 140 mg	Phase 3	Migraines	-	-
Telcagepant 300 mg soft gel capsules	Phase 3	Migraine	-	-
Leucovorin	Phase 3	Gastric Cancer	-	-
Rotarix™	Phase 3	Pneumococcal Infections	-	-
MK-3415	Phase 3	Clostridium Difficile Infection	-	-
Leucovorin/ levoleucovorin	Phase 3	Metastatic Colorectal Cancer	-	-
epinastine nasal spray, low concentration, low dose volume	Phase 3	Seasonal Allergic Rhinitis	-	-
Letermovir tablet	Phase 3	Cytomegalovirus Infection	-	-
peginterferon alfa-2b (PEG2b) (SCH 54031)	Phase 3	Hepatitis C, Chronic	-	-
Prulifloxacin	Phase 3	Acute Gastroenteritis in Adult Travelers	-	-
Efalizumab	Phase 3	Moderate to Severe Psoriasis	-	-
Suvorexant High Dose (HD)	Phase 3	Primary Insomnia	-	-
FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)	Phase 3	Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer	-	-
Sacituzumab Govitecan	Phase 3	Carcinoma, Non-Small-Cell Lung	-	-
Valganciclovir	Phase 3	CMV Disease	-	-
MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g)	Phase 3	Intra-abdominal Infection	-	-
Uridine 5'-Triphosphate (UTP) Solution for Inhalation	Phase 3	Lung Cancer	-	-
Glycopyrrolate	Phase 3	Surgical Procedures, Elective	-	-
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™)	Phase 3	Rotavirus	-	-
MK0524A, /Duration of Treatment : 4 Weeks	Phase 3	Flushing	-	-
Venetoclax	Phase 3	Leukemia, Lymphocytic, Chronic, B-Cell	-	-
Rebif® New Formulation (IFN-beta-1a, RNF)	Phase 3	Multiple Sclerosis, Relapsing-Remitting	-	-
Peginterferon alfa-2b (PEG)	Phase 3	Hepatitis C, Chronic	-	-
Ezetimibe	Phase 3	Hypercholesterolemia	-	-
Rocuronium bromide (Zemuron)	Phase 3	Anesthesia	-	-
Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine	Phase 3	Cervical Cancer	-	-
ART	Phase 3	HIV-1 Infection	-	-
Sitagliptin plus metformin	Phase 3	Type 2 Diabetes Mellitus	-	-
Linezolid	Phase 3	Pneumonia	-	-
liposomal doxorubicin	Phase 3	Breast Neoplasms	-	-
diquafosol tetrasodium (INS365) ophthalmic solution	Phase 3	Dry Eye Disease	-	-
REBETOL (ribavirin; SCH 18908)	Phase 3	Hepatitis C, Chronic	-	-
AzaSite	Phase 3	Bacterial Conjunctivitis	-	-
rosiglitazone	Phase 3	Type 2 Diabetes Mellitus	-	-
VARIVAX™ New Seed Process	Phase 3	Varicella	-	-
levoleucovorin	Phase 3	Esophageal Squamous Cell Carcinoma (ESCC)	-	-
V110	Phase 3	Pneumococcal Infection	-	-
Cetuximab plus Platinum-based Doublet Chemotherapy	Phase 3	Non-Small Cell Lung Cancer (NSCLC)	-	-
ribavirin (SCH 18908)	Phase 3	Hepatitis C, Chronic	-	-
MK-0524B	Phase 3	Primary Hypercholesterolemia	-	-
Cyclophosphamide	Phase 3	Diffuse Large B-Cell Lymphoma	-	-
L-PZQ ODT 50 mg/kg	Phase 3	Schistosomiasis	-	-
lovastatin	Phase 3	Atherosclerosis	-	-
MMRV (AMP)	Phase 3	Measles	-	-
Folinic Acid	Phase 3	Metastatic Colorectal Cancer	-	-
Lamivudine	Phase 3	HIV Infections	-	-
RotaTeq™ experimental formulation	Phase 3	Rotavirus Gastroenteritis	-	-
liraglutide	Phase 3	Diabetes Mellitus, Type 2	-	-
Ifinatamab Deruxtecan	Phase 3	Castration-Resistant Prostatic Cancer	-	-
Insulin Glargine	Phase 3	Type 2 Diabetes Mellitus	-	-
Bomedemstat	Phase 3	Thrombocythemia, Essential	-	-
Sulfonylurea	Phase 3	Type 2 Diabetes Mellitus	-	-
Pembrolizumab (MK-3475)	Phase 3	Merkel Cell Carcinoma	-	-
Hydroxyurea	Phase 3	Essential Thrombocythemia	-	-
Zidovudine	Phase 3	HIV Infections	-	-
Glimepiride	Phase 3	Type 2 Diabetes Mellitus	-	-
MK-0518	Phase 3	HIV Infections	-	-
Grazoprevir 100mg / Elbasvir 50 mg FDC	Phase 3	Chronic Hepatitis C Virus	-	-
Kuvan®	Phase 3	Phenylketonuria	-	-
Tulisokibart	Phase 3	Hidradenitis Suppurativa	-	-
Pioglitazone hydrochloride	Phase 3	Type 2 Diabetes Mellitus	-	-
Rebif®	Phase 3	Clinically Isolated Syndrome	-	-
Zoster Vaccine, Live, (Oka-Merck)	Phase 3	Varicella Virus Infection	-	-
Dapagliflozin	Phase 3	Type 2 Diabetes Mellitus	-	-
Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets	Phase 3	Chronic Hepatitis C	-	-
Zoster Vaccine, Live, (Oka-Merck), ZOSTAVAX™	Phase 3	Herpes Zoster	-	-
Sitagliptin 100 mg/simvastatin 40 mg FDC	Phase 3	Type 2 Diabetes Mellitus	-	-
Prevnar 13®	Phase 3	Streptococcus Pneumoniae Infection	-	-
Ertugliflozin 10 mg	Phase 3	Type 2 Diabetes Mellitus	-	-
MK0831	Phase 3	HIV Infections	-	-
Preservative-Free Tafluprost	Phase 3	Open-angle Glaucoma	-	-
Palivizumab	Phase 3	RSV Infection	-	-
Rotateq™	Phase 3	Rotavirus Infections	-	-
Clesrovimab	Phase 3	Respiratory Syncytial Viruses	-	-
ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live)	Phase 3	Measles	-	-
Filgrastim	Phase 3	Metastatic Non-small Cell Lung Cancer	-	-
granisetron	Phase 3	Chemotherapy-induced Nausea and Vomiting (CINV)	-	-
MK-8527	Phase 3	Human Immunodeficiency Virus (HIV)	-	-
PCV15 - Part B	Phase 3	Pneumococcal Disease	-	-
Zilovertamab vedotin	Phase 3	B-cell Acute Lymphoblastic Leukemia	-	-
Doravirine, Tenofovir, Lamivudine	Phase 3	HIV-1 Infection	-	-
Pembrolizumab/Quavonlimab	Phase 3	Colorectal Cancer	-	-
MK-5172A	Phase 3	Chronic Hepatitis C	-	-
PegIntron (peginterferon alfa-2b; SCH 54031)	Phase 3	Hepatitis	-	-
Grazoprevir	Phase 3	Chronic Hepatitis C (CHC)	-	-
PEG-Intron	Phase 3	Hepatitis C	-	-
Granulocyte Colony-Stimulating Factor (G-CSF)	Phase 3	DLBCL	-	-
Emtricitabine/tenofovir disoproxil (FTC/TDF)	Phase 3	Human Immunodeficiency Virus (HIV)	-	-
Zoster Vaccine, Live	Phase 3	Herpes Zoster	-	-
Efprezimod alfa	Phase 3	Graft Versus Host Disease	-	-
Zoster Vaccine, Live (AMP)	Phase 3	Herpes Zoster	-	-
Cisplatin/Carboplatin	Phase 3	Carcinoma, Squamous Cell of Head and Neck	-	-
ProQuad® manufactured with recombinant Human Albumin (rHA)	Phase 3	Measles	-	-
Gardasil™	Phase 3	Papillomavirus Infections	-	-
Fosaprepitant dimeglumine	Phase 3	Chemotherapy-Induced Nausea and Vomiting (CINV)	-	-
Aprepitant 125 mg	Phase 3	Chemotherapy Induced Nausea and Vomiting	-	-
Human Papillomavirus (HPV) 16 Monovalent	Phase 3	Cervical Cancer	-	-
PegIntron	Phase 3	Hepatitis C	-	-
Atropine	Phase 3	Anesthesia, General	-	-
Glycemic Rescue 1	Phase 3	Diabetes Mellitus	-	-
Axitinib	Phase 3	Renal Cell Carcinoma	-	-
Sitagliptin 100 mg q.d.+ Pioglitazone 45 mg q.d.	Phase 3	Type 2 Diabetes Mellitus	-	-
Androgen Deprivation Therapy (ADT)	Phase 3	Metastatic Hormone-Sensitive Prostate Cancer	-	-
Dacarbazine	Phase 3	Classical Hodgkin Lymphoma	-	-
Cisplatin (as radiosensitizer)	Phase 3	Endometrial Neoplasms	-	-
Peginterferon alfa-2b (PEG2b)	Phase 3	Hepatitis C, Chronic	-	-
Calderasib	Phase 3	Non-small Cell Lung Cancer	-	-
Metronidazole	Phase 3	Complicated Intra-abdominal Infections	-	-
H2 Receptor Antagonist	Phase 3	Non-small Cell Lung Cancer (NSCLC)	-	-
RotaTeq®	Phase 3	Meningitis, Meningococcal	-	-
Boceprevir (BOC)	Phase 3	Chronic Hepatitis C	-	-
Intismeran autogene	Phase 3	Bladder Cancer	-	-
MK0869, aprepitant	Phase 3	Postoperative Nausea and Vomiting	-	-
Cabozantinib	Phase 3	Renal Cell Carcinoma (RCC)	-	-
Pembrolizumab/Vibostolimab Co-Formulation	Phase 3	Small Cell Lung Carcinoma	-	-
Voriconazole	Phase 3	Aspergillosis	-	-
Short ragweed pollen allergen extract	Phase 3	Rhinitis, Allergic, Seasonal	-	-
MK0803, lovastatin	Phase 3	Hypercholesterolemia	-	-
Trifluridine-Tipiracil	Phase 3	Gastroesophageal Cancer	-	-
Rescue medication	Phase 3	Non-Muscle Invasive Bladder Cancer	-	-
Tisotumab Vedotin	Phase 3	Cervical Cancer	-	-
niacin (+) laropiprant	Phase 3	Hypercholesterolemia	-	-
TAS-102 (trifluridine and tipiracil)	Phase 3	Colorectal Neoplasms	-	-
Diquafosol tetrasodium ophthalmic solution, 2%	Phase 3	Dry Eye Disease	-	-
favezelimab/pembrolizumab	Phase 3	Hodgkin Lymphoma	-	-
Golimumab	Phase 3	Spondylitis, Ankylosing	-	-
TAS-102	Phase 3	Colorectal Cancer	-	-
Infliximab + methotrexate (MTX)	Phase 3	Arthritis, Rheumatoid	-	-
Atorvastatin	Phase 3	Mixed Hyperlipidemia	-	-
Pergoveris®	Phase 3	Infertility	-	-
Meropenem	Phase 3	Healthcare-Associated Pneumonia	-	-
Gefapixant 15 mg BID	Phase 3	Chronic Cough	-	-
Standard of Care (SOC)	Phase 3	Solid Tumors	-	-
Enalapril	Phase 3	Hypertension	-	-
Tedizolid phosphate	Phase 3	Acute Bacterial Skin and Skin Structure Infections	-	-
r-hCG	Phase 3	Infertility	-	-
Ceftolozane/Tazobactam	Phase 3	Complicated Intra-Abdominal Infection	-	-
SC golimumab	Phase 3	Arthritis, Rheumatoid	-	-
Sitagliptin 100 mg	Phase 3	Type 2 Diabetes Mellitus	-	-
Voglibose	Phase 3	Diabetes Mellitus, Non-Insulin-Dependent	-	-
ER-niacin	Phase 3	Primary Hypercholesterolaemia	-	-
MK-1293	Phase 3	Type 1 Diabetes Mellitus	-	-
CXA-201 and metronidazole	Phase 3	Complicated Intra-abdominal Infection	-	-
PAR-101/OPT-80	Phase 3	Clostridium Infections	-	-
Everolimus	Phase 3	Metastatic Breast Cancer	-	-
ZOSTAVAX™	Phase 3	Herpes Zoster	-	-
cetuximab + cisplatin + vinorelbine	Phase 3	Non Small Cell Lung Cancer (NSCLC)	-	-
sitagliptin 100 mg q.d./metformin ≥ 1500 mg/day	Phase 3	Type 2 Diabetes Mellitus (T2DM)	-	-
ER niacin (+) laropiprant (ERN/LRPT)	Phase 3	Dyslipidemia	-	-
Vancomycin (or equivalent)	Phase 3	Acute Hematogenous Osteomyelitis	-	-
MK0966; Rofecoxib / Duration of Treatment: 156 weeks	Phase 3	Colorectal Adenoma	-	-
Elbasvir	Phase 3	Hepatitis C	-	-
V260	Phase 3	Rotavirus Gastroenteritis	-	-
Vericiguat tablet	Phase 3	Heart Failure	-	-
Pegylated interferon alfa-2b (SCH 54031)	Phase 3	Hepatitis C, Chronic	-	-
MK-8591A	Phase 3	HIV-1 Infection	-	-
Prevenar 13™	Phase 3	Pneumococcal Infections	-	-
Imipenem	Phase 3	Bacterial Pneumonia	-	-
RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent	Phase 3	Vomiting	-	-
Zanzalintinib	Phase 3	Renal Cell Carcinoma	-	-
methotrexate	Phase 3	Psoriasis	-	-
5-FU	Phase 3	Metastatic Esophageal Squamous Cell Carcinoma	-	-
Vorinostat	Phase 3	Mesothelioma	-	-
Oxaliplatin	Phase 3	Colorectal Neoplasms	-	-
rolofylline	Phase 3	Heart Failure, Congestive	-	-
Patritumab Deruxtecan	Phase 3	Malignant Neoplasm	-	-
Gardasil	Phase 3	Papillomavirus Infections	-	-
Cetrorelix acetate	Phase 3	Polycystic Ovarian Syndrome	-	-
MK0966 / Duration of Treatment: 1 Days	Phase 3	Pain, Postoperative Arthroscopy	-	-
RotaTeq (V260)	Phase 3	Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9	-	-
Aprepitant	Phase 3	Post-operative Nausea	-	-
Frespaciguat	Phase 3	Pulmonary Hypertension	-	-
Pembrolizumab/Vibostolimab	Phase 3	Lung Neoplasms	-	-
caspofungin acetate	Phase 3	Fungal Infection	-	-
MK0826, ertapenem sodium	Phase 3	Infections	-	-
Pembrolizumab (+) Berahyaluronidase alfa	Phase 3	Lung Cancer	-	-
Paclitaxel	Phase 3	Metastatic Non-Small Cell Lung Cancer	-	-
MK-6072	Phase 3	Clostridium Difficile Infection	-	-
Gliclazide	Phase 3	Type 2 Diabetes Mellitus	-	-
MK-0524A	Phase 3	Hypercholesteremia	-	-
Supportive care measures	Phase 3	Non-small Cell Lung Cancer (NSCLC)	-	-
ZOSTAVAX™ (concomitant)	Phase 3	Herpes Zoster	-	-
Doxorubicin	Phase 3	Breast Neoplasms	-	-
MK0974 50 mg	Phase 3	Migraine	-	-
Vitamin D3	Phase 3	Osteoporosis	-	-
MK0869, aprepitant / Duration of Treatment: 3 days	Phase 3	Nausea	-	-
neostigmine and glycopyrrolate or atropine	Phase 3	Neuromuscular Blockade	-	-
INS365 Ophthalmic Solution	Phase 3	Keratoconjunctivitis Sicca	-	-
Glipizide	Phase 3	Diabetes Mellitus, Type 2	-	-
Dexamethasone	Phase 3	Metastatic Castration-resistant Prostate Cancer (mCRPC)	-	-
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®	Phase 3	Measles	-	-
regorafenib	Phase 3	Colorectal Cancer	-	-
sitagliptin phosphate (+) metformin hydrochloride	Phase 3	Type 2 Diabetes Mellitus	-	-
V110, pneumococcal vaccine polyvalent	Phase 3	Healthy	-	-
Sofosbuvir	Phase 3	Hepatitis C	-	-
Reformulated Raltegravir	Phase 3	HIV Infection	-	-
Background PAH Therapy	Phase 3	Pulmonary Arterial Hypertension	-	-
boceprevir (SCH 503034)	Phase 3	Chronic Hepatitis C	-	-
BIC/FTC/TAF	Phase 3	HIV-1 Infection	-	-
MK0991, caspofungin acetate / Duration of Treatment:	Phase 3	Fungal Infection	-	-
daptomycin	Phase 3	Pneumonia, Bacterial	-	-
Ertugliflozin 5 mg	Phase 3	Type 2 Diabetes Mellitus	-	-
Carboplatin	Phase 3	Carcinoma, Squamous Cell, Non-small-cell Lung	-	-
alvimopan	Phase 3	Ileus	-	-
pembrolizumab	Phase 3	Non-small Cell Lung Cancer	-	-
Nemtabrutinib	Phase 3	Chronic Lymphocytic Leukemia	-	-
Prevnar 13™	Phase 3	Pneumococcal Infections	-	-
Zoster Vaccine, Live (Zostavax™)	Phase 3	Shingles	-	-
DOR/ISL	Phase 3	HIV Infection	-	-
Rocuronium bromide (Org 9426)	Phase 3	Muscle Relaxation	-	-
Rocuronium 0.6 mg/kg intubating dose	Phase 3	Anesthesia	-	-
Rocuronium bolus maintenance	Phase 3	Anesthesia	-	-
V114	Phase 3	Pneumococcal Infections	-	-
sitagliptin phosphate	Phase 3	Type 2 Diabetes	-	-
Infliximab	Phase 3	Psoriasis	-	-
Ertugliflozin 15 mg	Phase 3	Type 2 Diabetes Mellitus	-	-
Metformin IR	Phase 3	Type 2 Diabetes Mellitus	-	-
Zoster Vaccine Live	Phase 3	Herpes Zoster	-	-
ER niacin/laropiprant	Phase 3	Diabetes Mellitus Type 2	-	-
Grazoprevir + Elbasvir	Phase 3	Hepatitis C Infection	-	-
Cetuximab + concomitant boost radiotherapy	Phase 3	Squamous Cell Carcinoma of the Head and Neck	-	-
L50/H12.5/A5	Phase 3	Hypertension	-	-
MK0826, /Duration of Treatment : 8 Weeks	Phase 3	Complicated Intra-Abdominal Infections	-	-
bortezomib	Phase 3	Multiple Myeloma	-	-
sugammadex	Phase 3	Neuromuscular Blockade	-	-
Tedizolid Phophate	Phase 3	Skin Diseases, Infectious	-	-
MK0507A, dorzolamide hydrochloride (+) timolol maleate	Phase 3	Glaucoma	-	-
MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 24 weeks	Phase 3	Osteoporosis	-	-
raltegravir potassium	Phase 3	HIV Infections	-	-
rotavirus vaccine, live, oral, pentavalent	Phase 3	Rotavirus Infections	-	-
Grazoprevir/Elbasvir	Phase 3	Hepatitis C	-	-
Temozolomide	Phase 3	Glioblastoma	-	-
Cisplatin	Phase 3	Gastric Neoplasms	-	-
laropiprant/niacin (MK0524A)	Phase 3	Hypercholesterolemia	-	-
Sitagliptin	Phase 3	Type 2 Diabetes Mellitus	-	-
9vHPV vaccine	Phase 3	Papillomavirus Infections	-	-
Gonal-f®	Phase 3	Assisted Reproductive Techniques	-	-
Ibrutinib	Phase 3	Chronic Lymphocytic Leukemia	-	-
COL-1620	Phase 3	Luteal Hormone Supplementation in In-vitro Fertilization	-	-
V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine	Phase 3	Diphtheria	-	-
V501	Phase 3	Human	-	-
losartan potassium (+) hydrochlorothiazide	Phase 3	Hypertension	-	-
Preladenant	Phase 3	Parkinson Disease	-	-
Opevesostat	Phase 3	Prostate Cancer Metastatic	-	-
Sotatercept	Phase 3	Pulmonary Arterial Hypertension	-	-
Bezlotoxumab	Phase 3	Clostridium Difficile Infection	-	-
PCV20	Phase 3	Pneumococcal Infection	-	-
Ertugliflozin	Phase 3	Type 2 Diabetes Mellitus	-	-
Peginterferon alfa-2b	Phase 3	Carcinoma, Hepatocellular	-	-
Ipragliflozin	Phase 3	Type 2 Diabetes Mellitus	-	-
Rocuronium bromide	Phase 3	Anesthesia	-	-
Pemetrexed	Phase 3	Carcinoma, Nonsquamous Non-small-cell Lung	-	-
IMI/REL	Phase 3	Suspected or Documented Gram-negative Bacterial Infection	-	-
MK0966, rofecoxib	Phase 3	Postoperative Pain	-	-
Posaconazole oral suspension	Phase 3	Mycoses	-	-
Follitropin alfa liquid formulation	Phase 3	Infertility	-	-
Micronised Progesterone	Phase 3	Infertility	-	-
Imipenem+Cilastatin/Relebactam	Phase 3	Complicated Intra-abdominal Infection	-	-
Doravirine	Phase 3	HIV-1	-	-
Telcagepant	Phase 3	Migraine	-	-
Lenvatinib	Phase 3	Non-small Cell Lung Cancer	-	-
V503 (9-valent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] vaccine)	Phase 3	Human Papillomavirus Infection	-	-
V116	Phase 3	Pneumococcal Infection	-	-
Omarigliptin	Phase 3	Type 2 Diabetes Mellitus	-	-
MR Prednisone	Phase 3	Rheumatoid Arthritis	-	-
Pembrolizumab 200 mg	Phase 3	Non-Small-Cell Lung Carcinoma	-	-
Cetuximab	Phase 3	Gastric Cancer	-	-
Combination of (a) pegylated interferon alfa-2b and (b) rebetol	Phase 3	Liver Transplantation	-	-
Gefapixant 45 mg twice daily (BID)	Phase 3	Chronic Cough	-	-
Gefapixant	Phase 3	Chronic Cough	-	-
Indinavir sulfate	Phase 3	HIV Infections	-	-
Ridaforolimus	Phase 3	Sarcoma	-	-
V503	Phase 3	Papillomavirus Infections	-	-
Saizen®	Phase 3	Fibromyalgia	-	-
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live	Phase 3	Measles	-	-
mFOLFOX6	Phase 3	Colorectal Carcinoma	-	-
Sitagliptin (MK0431)	Phase 3	Diabetes Mellitus, Type II	-	-
Cisplatin 100 mg/m^2	Phase 3	Head and Neck Neoplasms	-	-
Efavirenz	Phase 3	HIV Infections	-	-
Enlicitide Decanoate	Phase 3	Hypercholesterolemia	-	-
Odanacatib	Phase 3	Osteoporosis Postmenopausal	-	-
pegylated interferon alpha-2b	Phase 3	Hepatitis B, Chronic	-	-
V419	Phase 3	Bacterial Infections	-	-
Suvorexant	Phase 3	Insomnia	-	-
Rocuronium	Phase 3	Anesthesia, General	-	-
Gemcitabine	Phase 3	Biliary Tract Carcinoma	-	-
vaniprevir	Phase 3	Hepatitis C, Chronic	-	-
VARIVAX® PE34 Process	Phase 3	Varicella	-	-
Belzutifan	Phase 3	Renal Cell Carcinoma	-	-
Vorapaxar 2.5 mg	Phase 3	Cerebral Infarction	-	-
Rocurium	Phase 3	Anesthesia, General	-	-
Capecitabine	Phase 3	Advanced/Metastatic Gastroesophageal Adenocarcinoma	-	-
100 mg clindamycin /800 mg ketoconazole vaginal ovule	Phase 3	Vaginosis, Bacterial	-	-
QIV	Phase 3	Pneumonia, Pneumococcal	-	-
Acetaminophen/Paracetamol	Phase 3	Migraine Disorders	-	-
Ipilimumab	Phase 3	Melanoma	-	-
Alviompan	Phase 3	Bowel Dysfunction	-	-
taranabant	Phase 3	Smoking	-	-
Nab-paclitaxel	Phase 3	Non-small Cell Lung Cancer	-	-
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks	Phase 3	Measles	-	-
V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine / Duration of Treatment : 4 Years	Phase 3	Cervical Cancer	-	-
Enfortumab Vedotin	Phase 3	Urinary Bladder Cancer, Muscle-invasive	-	-
Cladribine Low Dose	Phase 3	Generalized Myasthenia Gravis	-	-
Metformin	Phase 3	Diabetes Mellitus	-	-
Colistimethate sodium (CMS)	Phase 3	Bacterial Infections	-	-
Acarbose	Phase 3	Type 2 Diabetes Mellitus	-	-
Fluorouracil (5-FU)	Phase 3	Urinary Bladder Neoplasms	-	-
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine	Phase 3	HPV Infections	-	-
2XP HEPTAVAX™-II SC	Phase 3	Hepatitis B	-	-
Abiraterone acetate	Phase 3	Prostatic Neoplasms	-	-
DOR	Phase 3	HIV-1 Infection	-	-
denufosol tetrasodium (INS37217) Inhalation Solution	Phase 3	Cystic Fibrosis	-	-
succinylcholine	Phase 3	Neuromuscular Blockade	-	-
MK-1084	Phase 3	Colon Adenocarcinoma	-	-
peg-IFN	Phase 3	Hepatitis C, Chronic	-	-
V503 Vaccine	Phase 3	Papillomavirus Infections	-	-
Saizen® A	Phase 3	Children Born With Serious Intra-uterine Growth Retardation	-	-
vinflunine	Phase 3	Urothelial Cancer	-	-
Modified Process Hepatitis B Vaccine	Phase 3	Hepatitis B	-	-
MK0557	Phase 3	Obesity	-	-
Pembrolizumab Formulated with Berahyaluronidase Alfa	Phase 3	Metastatic Non-small Cell Lung Cancer	-	-
Pneumovax™ 23	Phase 3	Pneumococcal Infections	-	-
Posaconazole	Phase 3	Mycoses	-	-
Metformin - Rescue	Phase 3	Diabetes Mellitus, Type 2	-	-
Infanrix® hexa	Phase 3	Varicella	-	-
IV Tulisokibart	Phase 3	Crohn's Disease	-	-
Daptomycin 4 mg/kg	Phase 3	Staphylococcal Infection	-	-
Gonalef® (Follitropin alfa)	Phase 3	Infertility	-	-
Fluconazole	Phase 3	Leukopenia	-	-
MK0826, ertapenem sodium / Duration of Treatment - 24 weeks	Phase 3	Foot Infections in Diabetic Patients	-	-
Naproxen	Phase 3	Endometriosis-related Pain	-	-
fidaxomicin	Phase 3	Clostridium Difficile-Associated Diarrhea (CDAD)	-	-
MK1903	Phase 2	Dyslipidemia	-	-
Grazoprevir (GZR)	Phase 2	Hepatitis C Virus	-	-
Ribavirin (RBV)	Phase 2	Hepatitis C, Chronic	-	-
denufosol tetrasodium Inhalation Solution	Phase 2	Cystic Fibrosis	-	-
CXA-101	Phase 2	Complicated Urinary Tract Infection	-	-
MK0916	Phase 2	Diabetes Mellitus, Type 2	-	-
V160	Phase 2	Cytomegalovirus (CMV) Infections	-	-
MK0524A, niacin (+) laropiprant / Duration of Treatment : 4 Weeks	Phase 2	Hypercholesterolemia	-	-
pegylated interferon	Phase 2	Chronic Hepatitis C	-	-
MK-2140 (zilovertamab vedotin)	Phase 2	Relapsed or Refractory Diffuse Large B-Cell Lymphoma	-	-
Antihistamine	Phase 2	Esophageal Squamous Cell Carcinoma	-	-
Multiple low dose cyclophosphamide	Phase 2	Multiple Myeloma	-	-
Rescue	Phase 2	Type II Diabetes Mellitus	-	-
Cabazitaxel	Phase 2	Prostatic Neoplasms, Castration-Resistant	-	-
L-dopa	Phase 2	Parkinson Disease	-	-
MK0364	Phase 2	Obesity	-	-
denufosol tetrasodium (INS37217)	Phase 2	Cystic Fibrosis	-	-
OPT-80	Phase 2	Diarrhea	-	-
Oral testosterone undecanoate (Andriol)	Phase 2	Hypogonadism	-	-
Single low dose cyclophosphamide	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
Azithromycin ophthalmic solution, 1%	Phase 2	Blepharitis	-	-
MK-8189	Phase 2	Schizophrenia, Acute Episode	-	-
Dalotuzumab	Phase 2	Carcinoma, Non-small-cell Lung	-	-
MK-8777	Phase 2	Depression	-	-
Vorapaxar	Phase 2	Atherosclerosis	-	-
ARQ 197	Phase 2	Pancreatic Neoplasms	-	-
Docetetaxel	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
V205C, measles, mumps, and rubella virus vaccine live	Phase 2	Measles	-	-
Recombinant human growth hormone (r-hGH)	Phase 2	Hypochondroplasia	-	-
ARQ 501	Phase 2	Cancer	-	-
Robatumumab	Phase 2	Colorectal Cancer	-	-
ADL5945 0.1 mg	Phase 2	Opioid Induced Constipation	-	-
MK0431, sitagliptin phosphate / Duration of Treatment: 21 Weeks	Phase 2	Diabetes Mellitus, Type II	-	-
I-DXd	Phase 2	Esophageal Squamous Cell Carcinoma	-	-
M5717 330 mg	Phase 2	Acute Malaria	-	-
Pertuzumab	Phase 2	Breast Neoplasms	-	-
epinastine 0.1%	Phase 2	Allergic Rhinitis	-	-
Stavudine	Phase 2	HIV Infections	-	-
Recombinant human follicle stimulating hormone (r-hFSH)	Phase 2	Infertility	-	-
MK-8998	Phase 2	Schizophrenia	-	-
Vibostolimab	Phase 2	Melanoma	-	-
MK0493	Phase 2	Obesity	-	-
MK0812 / Duration of Treatment: 12 Weeks	Phase 2	Arthritis, Rheumatoid	-	-
VigantOL oil plus interferon beta-1a (Rebif)	Phase 2	Relapsing-Remitting Multiple Sclerosis	-	-
Boserolimab	Phase 2	Small Cell Lung Cancer	-	-
SCH 56592	Phase 2	Onychomycosis	-	-
INS37217 Nasal Spray	Phase 2	Perennial Allergic Rhinitis	-	-
2 NRTIs	Phase 2	Human Immunodeficiency Virus (HIV) Infection	-	-
MK0777	Phase 2	Generalized Anxiety Disorder	-	-
PegIFN-2b	Phase 2	HIV Infections	-	-
medroxyprogesterone acetate tablets OR megestrol acetate	Phase 2	Endometrial Cancer	-	-
MK0524A, /Duration of Treatment : 8 Weeks	Phase 2	Flushing	-	-
Uprifosbuvir	Phase 2	Hepatitis C	-	-
PegIntron (peginterferon alfa-2b)	Phase 2	Hepatitis C, Chronic	-	-
Itraconazole	Phase 2	Chronic Hepatitis C	-	-
Pneumococcal Conjugate Vaccine (V114)	Phase 2	Pneumococcal Infections	-	-
Relebactam 250 mg	Phase 2	Intra-abdominal Infections	-	-
Atorvastatin/niacin extended-release	Phase 2	Carotid Atherosclerosis	-	-
V114 Aluminum-adjuvanted	Phase 2	Pneumococcal Infections	-	-
ARQ 197 plus erlotinib	Phase 2	Metastatic Non-Small Cell Lung Cancer	-	-
Vibostolimab/Pembrolizumab	Phase 2	Carcinoma, Renal Cell	-	-
Rebif	Phase 2	Multiple Sclerosis	-	-
MK-3120	Phase 2	Urothelial Carcinoma	-	-
MK0431, sitagliptin phosphate / Duration of Treatment: 12 Weeks	Phase 2	Type 2 Diabetes Mellitus	-	-
Dalantercept plus sorafenib	Phase 2	Advanced Adult Hepatocellular Carcinoma	-	-
Navarixin	Phase 2	Solid Tumors	-	-
Daptomycin for Injection	Phase 2	Bacteremia	-	-
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (V501)	Phase 2	HPV Infections	-	-
Nelfinavir mesylate	Phase 2	HIV Infections	-	-
UFOX + Cetuximab	Phase 2	Previously Untreated Metastatic Colorectal Cancer	-	-
Risperidone	Phase 2	Schizophrenia	-	-
Ritonavir	Phase 2	HIV Infections	-	-
Sacituzumab Tirumotecan (sac-TMT)	Phase 2	Gastroesophageal Junction	-	-
Pegylated Interferon (peg-IFN)	Phase 2	Hepatitis C	-	-
MK-0873	Phase 2	Rheumatoid Arthritis	-	-
Raludotatug Deruxtecan (R-DXd)	Phase 2	Gastrointestinal Cancer	-	-
Matuzumab	Phase 2	Esophageal Cancer	-	-
Posaconazole IV 6 mg/kg	Phase 2	Invasive Fungal Infection	-	-
Tepotinib	Phase 2	Non-small Cell Lung Cancer	-	-
V504	Phase 2	Cervical Cancer	-	-
AR51 (12, 10)	Phase 2	Bacterial Infections; Virus Diseases	-	-
MK-3795	Phase 2	VHL Gene Mutation	-	-
EV	Phase 2	Bladder Cancer	-	-
imipenem/cilastatin 500 mg	Phase 2	Urinary Tract Infections	-	-
MK0974	Phase 2	Migraine	-	-
V114 Lot 1	Phase 2	Pneumococcal Infections	-	-
diphenhydramine	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
Grazoprevir/Elbasvir FDC	Phase 2	Hepatitis C	-	-
cetuximab, cisplatin	Phase 2	Breast Neoplasm	-	-
luspatercept	Phase 2	B-Thalassemia	-	-
Interferon beta-1a	Phase 2	Alzheimer's Disease	-	-
MK-5442	Phase 2	Osteoporosis	-	-
V114 Medium Dose	Phase 2	Pneumococcal Infections	-	-
adavosertib	Phase 2	Ovarian Cancer	-	-
V181 High-Potency Level	Phase 2	Dengue Disease	-	-
MK-8616	Phase 2	Neuromuscular Blockade	-	-
Prednisolone	Phase 2	Lymphoma, Large B-Cell, Diffuse	-	-
cyclophosphamide (CPA)	Phase 2	Rectal Cancer	-	-
MK0249	Phase 2	Attention-Deficit/Hyperactivity Disorder (ADHD)	-	-
Biltricide (racemate praziquantel) oral tablets	Phase 2	Schistosomiasis	-	-
CXA-101/ tazobactam and metronidazole	Phase 2	Complicated Intra-abdominal Infection	-	-
Navarixin 10 mg	Phase 2	Psoriasis	-	-
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)	Phase 2	Infertility Implantation Failure	-	-
SCH 900636	Phase 2	Depressive Disorders	-	-
MK-8435 (Org 25935) 4-8 mg	Phase 2	Schizophrenia	-	-
Ifinatamab Deruxtecan (I-DXd)	Phase 2	Small Cell Lung Cancer	-	-
MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks	Phase 2	HIV Infections	-	-
ibuprofen	Phase 2	Migraine	-	-
Pegylated Lyposomal Doxorubicin	Phase 2	Breast Neoplasm	-	-
MK0782	Phase 2	Stomach Ulcer	-	-
MK-6096	Phase 2	Migraine	-	-
Pembrolizumab/vibostolimab coformulation	Phase 2	Bladder Cancer	-	-
EMD 525797 250 mg	Phase 2	Metastatic Colorectal Cancer	-	-
Ertugliflozin 25 mg	Phase 2	Diabetes Mellitus, Type 2	-	-
irinotecan hydrochloride	Phase 2	Metastatic Colorectal Cancer	-	-
MK8141	Phase 2	Hypertension	-	-
Doravirine, Tenofovir, Lamivudine - Blinded	Phase 2	HIV-1	-	-
MK-0941	Phase 2	Type 2 Diabetes Mellitus	-	-
V940	Phase 2	Squamous Non-small Cell Lung Cancer	-	-
Islatravir	Phase 2	HIV-1 Infection	-	-
R-DXD	Phase 2	Lung Neoplasm	-	-
Efinopegdutide	Phase 2	Metabolic Dysfunction-Associated Steatotic Liver Disease	-	-
Ramucirumab	Phase 2	Gastroesophageal Junction	-	-
Vaniprevir 600 mg b.i.d.	Phase 2	Hepatitis C, Chronic	-	-
Ruzasvir	Phase 2	Hepatitis C	-	-
M5717 60 mg	Phase 2	Malaria Infection	-	-
PRA023 IV	Phase 2	Crohn Disease	-	-
Gefitinib	Phase 2	Non-small Cell Lung Carcinoma	-	-
IDX719	Phase 2	Hepatitis C, Chronic	-	-
MK0822A	Phase 2	Vitamin D Deficiency	-	-
MK0633	Phase 2	Atherosclerosis	-	-
rolofyline	Phase 2	Congestive Heart Failure	-	-
RSV A Memphis 37b	Phase 2	Respiratory Syncytial Virus	-	-
Miransertib	Phase 2	PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)	-	-
tretinoin	Phase 2	Acute Myeloid Leukemia	-	-
Peg-interferon alfa-2b	Phase 2	Hepatitis C, Chronic	-	-
MK0826, ertapenem sodium /Duration of Treatment: 14 Days	Phase 2	Urinary Tract Infections	-	-
MK-0893	Phase 2	Diabetes Mellitus, Type 2	-	-
MK-1029 150 mg	Phase 2	Asthma	-	-
SCH 619734	Phase 2	Cough	-	-
Letermovir oral granules	Phase 2	Cytomegalovirus (CMV) Infection	-	-
Vicriviroc maleate	Phase 2	HIV	-	-
ZA	Phase 2	Breast Cancer	-	-
MK2295	Phase 2	Pain, Postoperative	-	-
ADL5747	Phase 2	Osteoarthritis of the Knee	-	-
L-756423	Phase 2	HIV Infections	-	-
TR-701 200 mg	Phase 2	Skin Diseases, Infectious	-	-
timolol/dorzolamide combination	Phase 2	Glaucoma	-	-
BCG	Phase 2	Urinary Bladder Neoplasms	-	-
vinblastine	Phase 2	Hodgkin Lymphoma	-	-
Esmeron®	Phase 2	Neuromuscular Blockade	-	-
Exemestane	Phase 2	Breast Neoplasms	-	-
r-hFSH	Phase 2	Infertility	-	-
Quavonlimab	Phase 2	Advanced Solid Tumors	-	-
S-1	Phase 2	Gastric Cancer	-	-
NM283 plus Peg-IFNα-2a	Phase 2	Chronic Hepatitis C	-	-
MK-1167	Phase 2	Alzheimer Disease	-	-
SCH 530348	Phase 2	Arterial Obstructive Diseases	-	-
Gefapixant 50 mg	Phase 2	Asthma	-	-
teicoplanin	Phase 2	Osteomyelitis	-	-
Epinastine Nasal Spray	Phase 2	Seasonal Allergic Rhinitis	-	-
MK0736	Phase 2	Hypertension	-	-
MK-2060	Phase 2	End-Stage Renal Disease	-	-
IDX184	Phase 2	Chronic Hepatitis C Infection	-	-
Pleconaril	Phase 2	Asthma	-	-
Gocatamig	Phase 2	Small-Cell Lung Cancer	-	-
MK633	Phase 2	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Avelumab	Phase 2	Squamous Non-Small Cell Lung Cancer	-	-
MK-4830	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
Lonafarnib	Phase 2	Breast Cancer	-	-
Efinopegdutide 20 mg/mL	Phase 2	Nonalcoholic Fatty Liver Disease	-	-
MK-1200	Phase 2	Advanced Solid Tumors	-	-
Doxorubicin hydrochloride	Phase 2	Breast Neoplasms	-	-
zoster vaccine live (Oka/Merck)	Phase 2	Shingles	-	-
r-FSH	Phase 2	Ovarian Stimulation	-	-
Raludotatug Deruxtecan	Phase 2	Ovarian Cancer Recurrent	-	-
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20	Phase 2	Papillomavirus Infections	-	-
SCH 727965	Phase 2	Breast Neoplasms	-	-
V114-A	Phase 2	Pneumococcal Infections	-	-
Coformulation favezelimab/pembrolizumab	Phase 2	Esophageal Squamous Cell Carcinoma (ESCC)	-	-
IFN beta 1a 44 mcg TIW	Phase 2	Multiple Sclerosis	-	-
Pegylated Liposomal Doxorubicin	Phase 2	Breast Neoplasm	-	-
Enclitide Chloride	Phase 2	Hypercholesterolemia	-	-
PR51 (3, 10)	Phase 2	Bacterial Infections; Virus Diseases	-	-
Tepotinib 300 mg	Phase 2	Carcinoma, Hepatocellular	-	-
coformulation pembrolizumab/quavonlimab	Phase 2	Small Cell Lung Carcinoma	-	-
Avastin	Phase 2	High-grade Serous Ovarian Carcinoma	-	-
ATRA	Phase 2	Melanoma	-	-
Atacicept	Phase 2	Rheumatoid Arthritis	-	-
Fosaprepitant	Phase 2	Chemotherapy-induced Nausea and Vomiting	-	-
Cilengitide 2000 mg once weekly	Phase 2	Squamous Cell Cancer	-	-
Vibegron	Phase 2	Urinary Bladder, Overactive	-	-
SCH 900271 15mg	Phase 2	Primary Hypercholesterolemia	-	-
Olaparib 400 mg	Phase 2	Metastatic Castration-Resistant Prostate Cancer	-	-
Org 34517	Phase 2	Depression	-	-
Gefapixant 45 mg	Phase 2	Chronic Cough	-	-
Farnesyl Protein Transferase Inhibitor	Phase 2	Leukemia	-	-
MK-1029	Phase 2	Asthma	-	-
Palbociclib	Phase 2	Renal Cell Carcinoma	-	-
ADL5859	Phase 2	Peripheral Neuropathy	-	-
MK2461	Phase 2	Neoplasm	-	-
Dabrafenib	Phase 2	Melanoma	-	-
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate	Phase 2	HIV-1 Infection	-	-
MK5757	Phase 2	Schizophrenia	-	-
Coformulated favezelimab/pembrolizumab	Phase 2	Metastatic Urothelial Carcinoma	-	-
MK0991, caspofungin acetate	Phase 2	Aspergillosis	-	-
SCH 486757	Phase 2	Cough	-	-
Tecemotide (L-BLP25)	Phase 2	Lung Neoplasms	-	-
measles, mumps, and rubella virus vaccine live	Phase 2	Measles	-	-
MK0686	Phase 2	Pain, Postoperative	-	-
MK0524A, niacin (+) laropiprant / Duration of Treatment: 17 Weeks	Phase 2	Flushing	-	-
val-mCyd	Phase 2	Chronic Hepatitis C	-	-
Vecuronium	Phase 2	Anesthesia, General	-	-
Samatasvir	Phase 2	Chronic Hepatitis C Virus	-	-
AS900672-Enriched 50 microgram (mcg)	Phase 2	Infertility	-	-
ridaforolimus (MK8669)	Phase 2	Prostate Cancer	-	-
Sitagliptin 25 mg	Phase 2	Glucose Intolerance	-	-
MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA) / Duration of Treatment 6 Months	Phase 2	B-cell Lymphoma	-	-
Cilengitide	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
Donepezil	Phase 2	Alzheimer's Disease	-	-
ADL5859 30 mg	Phase 2	Acute Pain	-	-
Ulevostinag	Phase 2	Head and Neck Squamous Cell Carcinoma (HNSCC)	-	-
ecallantide	Phase 2	Bloodloss	-	-
Rolapitant Dose 1	Phase 2	Postoperative Nausea and Vomiting	-	-
Gefapixant 100 mg	Phase 2	Refractory Chronic Cough	-	-
MK3207- 2.5 mg	Phase 2	Migraine	-	-
MK0359	Phase 2	Pulmonary Disease, Chronic Obstructive	-	-
Pembrolizumab (neoadjuvant)	Phase 2	Lung Neoplasm Malignant	-	-
MK0518	Phase 2	HIV Infections	-	-
ADL5945 0.25 mg	Phase 2	Constipation	-	-
Vicriviroc 30 mg	Phase 2	HIV Infections	-	-
valopicitabine	Phase 2	Chronic Hepatitis C	-	-
MK0677	Phase 2	Alzheimer's Disease	-	-
MK-5684	Phase 2	Malignant Neoplasm	-	-
MK-6213	Phase 2	Hypercholesterolemia	-	-
Ertugliflozin 1 mg	Phase 2	Diabetes Mellitus, Type 2	-	-
MK0429	Phase 2	Post-Menopausal Osteoporosis	-	-
M5049 low dose	Phase 2	Systemic Lupus Erythematosus	-	-
MK0524	Phase 2	Seasonal Allergies	-	-
ARQ 501 in combination with gemcitabine	Phase 2	Pancreatic Cancer	-	-
MK0991, caspofungin acetate/Duration of Treatment: variable	Phase 2	Candidiasis	-	-
peginterferon alfa 2b	Phase 2	Hepatitis C, Chronic	-	-
Pegylated Interferon Alfa	Phase 2	Chronic Hepatitis C	-	-
KW-3902IV	Phase 2	Heart Failure, Congestive	-	-
Favezelimab	Phase 2	Advanced Non-Small Cell Lung Cancer	-	-
tildrakizumab	Phase 2	Psoriasis	-	-
SCH 900538	Phase 2	Seasonal Allergic Rhinitis	-	-
TS-1	Phase 2	Gastric Cancer	-	-
EBR/GZR FDC Tablet	Phase 2	HCV Infection	-	-
TRUVADA®	Phase 2	HIV Infections	-	-

Hepatitis C, Chronic

1 drug in this indication

Breast Cancer

1 drug in this indication

Dyslipidemia

1 drug in this indication

Hepatitis C

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Regulatory Approvals

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

MERCK

Market Overview

MRK News

Catalyst Timeline

Belzutifan Phase 2 Results Expected

Frespaciguat Phase 2 Results Expected

Pipeline & FDA Submissions

Competitive Positions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals